CD34 positive progenitors can be cytogenetically normal in patients with myelodysplastic syndromes (MDS).

被引：0
|
作者：
Abruzzese, E
Radford, JE
Pettenati, MJ
Rao, PN
Hurd, DD
Rainer, RO
Powell, BL
Torti, FM
机构：
[1] WAKE FOREST UNIV,CTR COMPREHENS CANC,WINSTON SALEM,NC 27109
[2] UNIV ROMA TOR VERGATA,CATTEDRA EMATOL,ROME,ITALY
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1906 / 1906
页数：1
相关论文
共 50 条
  • [1] CD34 Expression by Megakaryocytes in Myelodysplastic Syndromes
    Butler, S. L.
    Boonsakan, P.
    Grier, D. D.
    Li, Y.
    Braylan, R. C.
    Al-Quran, S. Z.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 256A - 256A
  • [2] Expression of CD34 by megakaryocytes In myelodysplastic syndromes
    Pellegrini, W
    Facchetti, F
    Marocolo, D
    Pelizzari, AM
    Capucci, A
    Rossi, G
    [J]. HAEMATOLOGICA, 2000, 85 (10) : 1117 - 1118
  • [3] CD34 Expression by Megakaryocytes in Myelodysplastic Syndromes
    Butler, S. L.
    Boonsakan, P.
    Grier, D. D.
    Li, Y.
    Braylan, R. C.
    Al-Quran, S. Z.
    [J]. MODERN PATHOLOGY, 2009, 22 : 256A - 256A
  • [4] Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML
    Quaini, Federico
    Fioretzaki, Rodanthi
    Crugnola, Monica
    Falco, Angela
    Madeddu, Denise
    Craviotto, Luisa
    Cambo, Benedetta
    Prezioso, Lucia
    Sammarelli, Gabriella
    Todaro, Giannalisa
    Graiani, Gallia
    Mancini, Cristina
    Martella, Eugenia
    Re, Francesca
    Giuliani, Nicola
    Aversa, Franco
    [J]. BLOOD, 2016, 128 (22)
  • [5] Analysis of Mesenchymal Stromal Cells (MSC) and their Interactions with CD34 Stem and Progenitor Cells in Patients with Myelodysplastic Syndromes (MDS)
    Geyh, Stefanie
    Cadeddu, Ron Patrick
    Froebel, Julia
    Bruns, Ingmar
    Zohren, Fabian
    Huenerlituerkoglu, Ali-Nuri
    Kobbe, Guido
    Gattermann, Norbert
    Germing, Ulrich
    Haas, Rainer
    Schroeder, Thomas
    [J]. BLOOD, 2011, 118 (21) : 1030 - 1030
  • [6] Circulating CD34+ cells in the myelodysplastic syndromes (MDS).
    Cairoli, R
    Pezzetti, L
    Intropido, L
    Brando, B
    Santoleri, L
    Nosari, A
    Perego, RA
    Morra, E
    [J]. BLOOD, 1995, 86 (10) : 3152 - 3152
  • [7] CD34 expression in various FAB subtypes of myelodysplastic syndromes
    Wang, GS
    Shidham, V
    Kampalath, B
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 560 - 560
  • [8] CD34+ cells have a lower in vivo labeling index (LI) than CD34 negative cells in myelodysplastic syndromes (MDS).
    Span, L
    Shetty, V
    BroadyRobinson, L
    Mundle, SD
    Alvi, S
    Borok, R
    Reza, S
    Dar, S
    Boukhris, T
    Kumar, R
    Venugopal, P
    Gezer, S
    Robin, E
    Rifkin, S
    Hines, C
    Raza, A
    [J]. BLOOD, 1996, 88 (10) : 365 - 365
  • [9] In vitrodevelopment of haemopoietic progenitors in myelodysplastic syndromes (MDS)
    S Tauro
    DT Bowen
    SJL Brada
    JThM de Wolf
    DW Hendriks
    JW Smit
    E Vellenga
    [J]. Leukemia, 1999, 13 : 494 - 495
  • [10] ANALYSIS OF CELL-CYCLE STATUS AND RESPONSIVENESS TO CYTOKINES OF CD34 AND CD54 POSITIVE CELLS IN NORMAL AML AND MDS MARROW PROGENITORS
    BROWN, AR
    SMITH, MA
    SMITH, JG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 28 - 28
12345